Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP789867.RASe71tjmFGTFY9Pxa-vO4v_qnhFAsWmAk9IkxEqV-f2w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP789867.RASe71tjmFGTFY9Pxa-vO4v_qnhFAsWmAk9IkxEqV-f2w130_assertion type Assertion NP789867.RASe71tjmFGTFY9Pxa-vO4v_qnhFAsWmAk9IkxEqV-f2w130_head.
- NP789867.RASe71tjmFGTFY9Pxa-vO4v_qnhFAsWmAk9IkxEqV-f2w130_assertion description "[Despite the low incidence of FGFR2 mutations in ovarian cancer, the two FGFR2 mutations identified in ovarian tumors (S252W, Y376C) overlap with the oncogenic mutations previously identified in endometrial tumors, suggesting activated FGFR2 may contribute to ovarian cancer pathogenesis in a small subset of ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789867.RASe71tjmFGTFY9Pxa-vO4v_qnhFAsWmAk9IkxEqV-f2w130_provenance.
- NP789867.RASe71tjmFGTFY9Pxa-vO4v_qnhFAsWmAk9IkxEqV-f2w130_assertion evidence source_evidence_literature NP789867.RASe71tjmFGTFY9Pxa-vO4v_qnhFAsWmAk9IkxEqV-f2w130_provenance.
- NP789867.RASe71tjmFGTFY9Pxa-vO4v_qnhFAsWmAk9IkxEqV-f2w130_assertion SIO_000772 20106510 NP789867.RASe71tjmFGTFY9Pxa-vO4v_qnhFAsWmAk9IkxEqV-f2w130_provenance.
- NP789867.RASe71tjmFGTFY9Pxa-vO4v_qnhFAsWmAk9IkxEqV-f2w130_assertion wasDerivedFrom befree-2016 NP789867.RASe71tjmFGTFY9Pxa-vO4v_qnhFAsWmAk9IkxEqV-f2w130_provenance.
- NP789867.RASe71tjmFGTFY9Pxa-vO4v_qnhFAsWmAk9IkxEqV-f2w130_assertion wasGeneratedBy ECO_0000203 NP789867.RASe71tjmFGTFY9Pxa-vO4v_qnhFAsWmAk9IkxEqV-f2w130_provenance.